Trial Profile
An observational study to evaluate the relative survival in pre- and post-sorafenib era in elderly patients with advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Acronyms SEER
- 23 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology